Nov 17, 2021 / 09:00PM GMT
Operator
Thank you for standing by, and welcome to the AFT Pharmaceuticals' 2021 Half Year Results Analyst Briefing. (Operator Instructions)
I would now like to hand the conference over to Hartley Atkinson, CEO. Please go ahead.
Hartley Atkinson - AFT Pharmaceuticals Limited - Founder, CEO, MD & Executive Director
Good. Thank you very much, and welcome, everyone, to the presentation of our half year FY 2022 investor presentation. Now the presentation is on the website. So I'll just be going through that, and I'll read out the page numbers as I go.
So looking through Page #2, is the standard disclaimer notice. So if you could please take [event] to as read.
And then looking to Page #3, what we have here is looking at our growth over this time period, we've had on the top figure, 1H 2022. You can see we have $55 million of sales revenues from total operations, which is a 14% increase on the prior year. And looking down at the bottom graphs, we have operating profit on the left, and that shows we've got about 2.3x improvement in our half
Half Year 2022 AFT Pharmaceuticals Ltd Earnings Call Transcript
Nov 18, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers